email exchange with michael, page-104

Hi dc1234,

Thank you for your courteous response

If he actually wrote he was NOT worried about short term sp decline, yes that would change my opinion on this point as my response was directly related to the title post where it stated, "He said he is also concerned about the share price decline"

My post appeared to upset a few holders yesterday so I'm happy to drop the email topic and get back to discussing the company. For the record however I was serious dc, but it wasn't your email reply so much as the first one posted sometime ago by greendayone - which I initially thought was only a silly prank.

And in response to other posters on this thread who suggest non-holders are only downramping to bring the price down for getting their fills please understand that any effort to manipulate ISN's sp up or down on hc will prove futile while Bergen are in charge. They have control both up and down (along with Paterson's under the guise of Celtic) Imo.
___

Isonea as I understand have named "AsthmaSense" as their mobile application platform - please correct me if I'm wrong

The UCSF Medical School Clinical faculty and the director of Tri-Valley Pediatrics in 2010 created the following Asthma iphone app called AsthmaMD

What I find interesting and would appreciate other opinions on, is that the backdrop picture used for this AsthmaMD website is the same as what appears on many of KarmelSonix's presentations, brochures and website.

Does anyone here think that asthmaMD forms any part of Isonea's application platform or is it just a coincidence?

asthmaMD - mobile app
___

With regards to the mobilehealthnews article speculating a partnership with Michael's former employee, GSK, I can say with some confidence that Glaxo's mobile app for asthma management, MyAsthma was developed with UK company Digital Reply last year and was launched about 4 weeks ago.

MyAsthma - mobile app demo video - GSK

MyAsthma - mobile app - GlaxoSmithKline